Company Presentation
TOLREMO therapeutics AG
| Country: | Switzerland |
| Category: | Emerging Biotech Company Presentation |
| Room: | Singapore |
| Date: | 02.05.2022 |
| Time: | 15:45–16:00 |
| Website: | www.tolremo.com |
| Speaker: | Stefanie Flückiger-Mangual |
Company profile
TOLREMO is a cancer drug resistance company spun out of the ETH Zurich in Switzerland, one of the leading science universities in the world. TOLREMO uses a proprietary drug screening and development platform to develop small molecules that inhibit non-genetic resistance mechanisms (persister cells; adaptive resistance). They can be used in combination with blockbuster cancer drugs such as EGFR or KRAS inhibitors to prevent resistance development. FIH is planned for H1 2023.
